indulge
发表于 2025-3-21 19:39:51
书目名称Molecular Mixed Crystals影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0638395<br><br> <br><br>书目名称Molecular Mixed Crystals影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0638395<br><br> <br><br>书目名称Molecular Mixed Crystals网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0638395<br><br> <br><br>书目名称Molecular Mixed Crystals网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0638395<br><br> <br><br>书目名称Molecular Mixed Crystals被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0638395<br><br> <br><br>书目名称Molecular Mixed Crystals被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0638395<br><br> <br><br>书目名称Molecular Mixed Crystals年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0638395<br><br> <br><br>书目名称Molecular Mixed Crystals年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0638395<br><br> <br><br>书目名称Molecular Mixed Crystals读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0638395<br><br> <br><br>书目名称Molecular Mixed Crystals读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0638395<br><br> <br><br>
harmony
发表于 2025-3-21 20:31:44
http://reply.papertrans.cn/64/6384/638395/638395_2.png
SMART
发表于 2025-3-22 02:32:37
http://reply.papertrans.cn/64/6384/638395/638395_3.png
harrow
发表于 2025-3-22 06:39:54
http://reply.papertrans.cn/64/6384/638395/638395_4.png
耕种
发表于 2025-3-22 11:11:42
http://reply.papertrans.cn/64/6384/638395/638395_5.png
职业拳击手
发表于 2025-3-22 14:00:46
Miquel Àngel Cuevas-Diarte,Harry A. J. OonkRepresents the one and only state-of-the-art successor of Kitaigorodskii‘s famous "Mixed Crystals" (Springer 1984).Offers a benchmark volume for the study of mixed crystals.Features contributions of r
开花期女
发表于 2025-3-22 18:45:47
http://reply.papertrans.cn/64/6384/638395/638395_7.png
FAZE
发表于 2025-3-22 21:18:40
http://reply.papertrans.cn/64/6384/638395/638395_8.png
即席
发表于 2025-3-23 04:38:10
http://reply.papertrans.cn/64/6384/638395/638395_9.png
jarring
发表于 2025-3-23 06:40:21
Sustainability and DiscontinuityTreatment with long-acting non-sedating H1-antihistamines is effective in over 50% of cases, but when not, other therapies such as biologics, immunosuppressive agents, or other anti-inflammatory agents may be necessary to control the hives.